We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: orth America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Therapeutic indications
Meropenem for Injection is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:
• Community acquired lower respiratory tract infection
• Hospital acquired lower respiratory tract infection
• Complicated urinary tract infection
• Febrile neutropenia
• Intra-abdominal and gynaecological (polymicrobial) infections
• Complicated skin and skin structure infections
• Meningitis
• Septicaemia .
Dose and method of administration
Dose
Adults
500 mg to 1 g by intravenous administration every 8 hours depending on type and severity of
infection, the known or expected susceptibility of the pathogen(s) and the condition of the
patient.
Exceptions
1. Febrile episodes in neutropenic patients - the dose should be 1 g every 8 hours.
2. Meningitis - the dose should be 2 g every 8 hours.
More information follow all directions given to you by your doctor and pharmacist carefully
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
